| 标题 |
 Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment: Results of the prospective PONS trial |
| 网址 | |
| DOI |
10.1159/000545826
doi
|
| 其它 |
期刊：Acta Haematologica 作者：Philipp le Coutre; Andreas Burchert; Susanne Saußele; Tobias Schwarzer; Sebastian Stintzing; et al 出版日期：2025-05-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
凌凌
cdercder
无极微光
水煮电吹风
欧克
v0id
学术文献互助
Kao
Nole
GingerF
唠叨的大门
DOC_XIONG
Loscipy
DW
Criminology34
OK
谢雷XIELei
铁锤牛马版
七听
xing_xing
皖公网安备34019202002308
